A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/19 (2006.01) A61K 9/00 (2006.01) A61K 9/16 (2006.01) A61K 38/17 (2006.01) A61K 38/22 (2006.01) A61K 47/30 (2006.01)
Patent
CA 2213560
A controlled release pharmaceutical composition includes a biocompatible polymeric material, preferably polyethylene-vinyl acetate or poly(lactic- glucolic acid), having incorporated therein a soluble receptor capable of binding to its ligand and thus affecting the ligand's function. The soluble receptor is preferably the soluble form of TNF.alpha. receptor. Such compositions are for use in the treatment of disorders in which neutralization of the deleterious effects of TNF.alpha. is required.
Composition pharmaceutique à libération régulée qui comporte un matériau polymère biocompatible, de préférence de l'acétate de polyéthylène-vinyle ou de l'acide poly(lactique-glucolique), contenant un récepteur soluble capable de se lier à son ligand et partant d'affecter la fonction dudit ligand. Ledit récepteur soluble est de préférence la forme soluble du récepteur de TNF.alpha.. Lesdites compositions sont utiles pour traiter des troubles dans lesquels la neutralisation des effets délétères de TNF.alpha. est requise.
Eliaz Rom
Kost Josef
Wallach David
Ben-Gurion University Of The Negev
Borden Ladner Gervais Llp
Yeda Research And Development Co. Ltd.
LandOfFree
Pharmaceutical compositions for controlled release of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions for controlled release of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for controlled release of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2043569